The correlation between serum myostatin levels and muscle mass [72] and reports of elevated myostatin levels in the elderly [73] suggest that myostatin inhibitors may be effective in preventing muscle atrophy in actual clinical practice. The gene discussed is MSTN; the disease is muscle atrophy.